SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS

USPTO USPTO 2007 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS was filed as Word and figurative mark on 08/09/2007 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 09/23/2008. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: June 7, 2018

Trademark form Word and figurative mark
File reference 77250843
Register number 3503812
Application date August 9, 2007
Publication date July 8, 2008
Entry date September 23, 2008

Trademark owner

103-105 BATH ROAD
SL1 3UH SLOUGH
GB

Trademark representatives

goods and services

44 Provision of healthcare advice; providing information relating to opioid dependence

ID: 1377250843